Literature DB >> 11136693

Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study.

V Palmieri1, J N Bella, D K Arnett, J E Liu, A Oberman, M Y Schuck, D W Kitzman, P N Hopkins, D Morgan, D C Rao, R B Devereux.   

Abstract

BACKGROUND: Type 2 diabetes is a cardiovascular risk factor. It remains to be elucidated in a large, population-based sample whether diabetes is associated with changes in left ventricular (LV) structure and systolic function independent of obesity and systolic blood pressure (BP). METHODS AND
RESULTS: Among 1950 hypertensive participants in the HyperGEN Study without overt coronary heart disease or significant valve disease, 20% (n=386) had diabetes. Diabetics were more likely to be women, black, older, and have higher BMI and waist/hip ratio than were nondiabetics. After adjustment for age and sex, diabetics had higher systolic BP, pulse pressure, and heart rate; lower diastolic BP; and longer duration of hypertension than nondiabetics. LV mass and relative wall thickness were higher in diabetic than nondiabetic subjects independent of covariates. Compared with nondiabetic hypertensives, diabetics had lower stress-corrected midwall shortening, independent of covariates, without difference in LV EF. Insulin levels and insulin resistance were higher in non-insulin-treated diabetics (n=195) than nondiabetic (n=1439) subjects (both P:<0.01). Insulin resistance positively but weakly related to LV mass and relative wall thickness.
CONCLUSIONS: In a relatively healthy, population-based sample of hypertensive adults, type 2 diabetes was associated with higher LV mass, more concentric LV geometry, and lower myocardial function, independent of age, sex, body size, and arterial BP. structural and functional abnormalities in addition to, and independent of, atherosclerosis.(13) (14) In the Framingham cohort, diabetes was associated with higher LV mass in women but not men.(15) High blood pressure (BP), obesity, and abnormal lipid profile, which often coexist with diabetes, tend to be associated with preclinical cardiovascular abnormalities(16) and may contribute to the association of diabetes with cardiovascular events. Cardiac features of diabetic and nondiabetic hypertensive subjects remain incompletely described in population-based samples. Therefore, we compared clinical and metabolic characteristics, LV geometry, and systolic function between diabetic and nondiabetic hypertensive participants in the Hypertension Genetic Epidemiology Network (HyperGEN) Study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136693     DOI: 10.1161/01.cir.103.1.102

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  78 in total

Review 1.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

Review 2.  Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes.

Authors:  Fida Bacha; Samuel S Gidding
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

Review 3.  Alterations in cardiac structure and function in hypertension.

Authors:  Mário Santos; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

Review 4.  Effect of glucose-lowering therapies on heart failure.

Authors:  Michael Nassif; Mikhail Kosiborod
Journal:  Nat Rev Cardiol       Date:  2018-01-25       Impact factor: 32.419

5.  Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease.

Authors:  Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Eur J Heart Fail       Date:  2010-03-07       Impact factor: 15.534

Review 6.  Echocardiographic feature of diabetic cardiomyopathy: where are we now?

Authors:  Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

Review 7.  Myocardial remodeling in hypertension.

Authors:  W Nadruz
Journal:  J Hum Hypertens       Date:  2014-05-08       Impact factor: 3.012

8.  ACE gene polymorphism and cardiac structure in patients with insulin resistance.

Authors:  Fulya Akin; Sebahat Turgut; Dursun Dursunoglu; Gunfer Turgut; Ugur Karasu; Sukru Gur
Journal:  Mol Biol Rep       Date:  2008-03-18       Impact factor: 2.316

Review 9.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

10.  The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota.

Authors:  Sanjay Dandamudi; Joshua Slusser; Douglas W Mahoney; Margaret M Redfield; Richard J Rodeheffer; Horng H Chen
Journal:  J Card Fail       Date:  2014-02-24       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.